Skip to content

13F-HR filed by Logos Global Management LP

Logos Global Management LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 57 holding rows worth $1,386,784,000.

Accession
0001172661-21-002272
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 57 entries on the cover page, a total value of $1,386,784,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,386,784,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK3,156,981$233,175,000thousands by filing date
OLEMA PHARMACEUTICALS INC68062P106COM3,743,875$103,181,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM1,850,000$62,863,000thousands by filing date
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS1,475,000$61,345,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock3,619,392$58,779,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM460,000$56,272,000thousands by filing date
FORMA THERAPEUTICS HLDGS INC34633R104SHS2,115,000$49,047,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM1,450,000$47,792,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock1,775,000$45,245,000thousands by filing date
COMPASS PATHWAYS PLC20451W101SPONSORED ADS1,400,000$41,818,000thousands by filing date
PMV PHARMACEUTICALS INC69353Y103COM1,400,000$41,720,000thousands by filing date
DESIGN THERAPEUTICS INC25056L103COM2,772,501$40,728,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM1,160,251$37,998,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW1,000,000$35,740,000thousands by filing date
NKARTA INC65487U108COMMON STOCK1,275,777$35,479,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM4,100,000$35,424,000thousands by filing date
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock1,962,785$30,443,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW510,000$30,371,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM1,500,000$24,675,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock1,277,091$22,828,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM443,265$20,833,000thousands by filing date
LANDOS BIOPHARMA INC515069102CMN1,405,000$20,513,000thousands by filing date
GRAPHITE BIO INC38870X104COM1,206,308$19,771,000thousands by filing date
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS1,069,545$17,861,000thousands by filing date
TYRA BIOSCIENCES INC90240B106COMMON STOCK1,003,394$17,650,000thousands by filing date
ATHIRA PHARMA INC04746L104COM1,855,812$17,408,000thousands by filing date
CENTURY THERAPEUTICS INC15673T100COM639,095$16,080,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM2,000,000$14,860,000thousands by filing date
PRELUDE THERAPEUTICS INC74065P101CMN400,000$12,500,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM500,000$12,330,000thousands by filing date
EDGEWISE THERAPEUTICS INC28036F105COM681,812$10,752,000thousands by filing date
BIOMEA FUSION INC09077A106CMN702,320$8,407,000thousands by filing date
ELEDON PHARMACEUTICALS INC28617k101COM1,339,793$8,280,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW1,000,000$8,000,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW700,000$7,917,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM925,000$7,779,000thousands by filing date
ATRECA INC04965G109COM1,175,000$7,320,000thousands by filing date
TALARIS THERAPEUTICS INC87410C104COM507,923$6,887,000thousands by filing date
RAIN ONCOLOGY INC75082Q105COM465,331$6,613,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM288,458$6,510,000thousands by filing date
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock324,333$6,439,000thousands by filing date
JANUX THERAPEUTICS INC47103J105COM247,122$4,811,000thousands by filing date
SYNLOGIC INC87166L100COM1,500,000$4,575,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM425,000$4,535,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK200,000$4,076,000thousands by filing date
IKENA ONCOLOGY INC45175G108COM299,853$3,784,000thousands by filing date
Day One Biopharmaceuticals Inc23954D109Common Stock52,069$2,798,000thousands by filing date
NUVALENT INC COM670703107Stock134,650$2,733,000thousands by filing date
SOMALOGIC INC83444K105COM200,493$2,236,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM94,345$2,172,000thousands by filing date
OMEGA THERAPEUTICS INC68217N105COMMON STOCK88,235$1,663,000thousands by filing date
PASSAGE BIO INC702712100COM125,010$1,245,000thousands by filing date
MONTE ROSA THERAPEUTICS INC61225M102COM50,000$1,114,000thousands by filing date
KEROS THERAPEUTICS INC COM492327101Stock15,000$593,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM20,000$525,000thousands by filing date
NUVATION BIO INC67080N119WARR66,666$177,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN46,984$114,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-21-002272this filing2021-11-15acceptance time not in the bulk data set